Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AGfiledCriticalBayer Pharma AG
Publication of ECSP12011636ApublicationCriticalpatent/ECSP12011636A/en
Medical Preparation Storing Or Oral Administration Devices
(AREA)
Infusion, Injection, And Reservoir Apparatuses
(AREA)
Abstract
Para un control seguro y sencillo de la toma de dosis de medicamentos Ta se crea un dispositivo indicador para un distribuidor de dosis de medicamentos Ta, donde las dosis de medicamentos deben tomarse en horarios de toma referenciales que se repiten regularmente y donde el dispositivo indicador comprende una pantalla de visualización 1 así como un direccionamiento electrónico para la pantalla de visualización, caracterizados porque la pantalla de visualización comprende un primer elemento de visualización 30, 40 para representar un primer período de tiempo entre un primer horario de toma referencial y el horario actual y el primer horario de toma referencial se caracteriza porque las dosis de medicamento no ha sido tomada hasta el primer horario de toma referencial.For a safe and simple control of the dose of medication Ta, an indicator device is created for a distributor of dose of medication Ta, where the dose of medication should be taken at reference times that are repeated regularly and where the indicator device comprises a display screen 1 as well as an electronic addressing for the display screen, characterized in that the display screen comprises a first display element 30, 40 to represent a first period of time between a first reference time and the current schedule and The first referential intake schedule is characterized in that the medication doses have not been taken until the first referential intake schedule.
ECSP120116362009-07-302012-01-30
INDICATOR DEVICE FOR A MEDICATION DOSE DISTRIBUTOR AS WELL AS ITS USE
ECSP12011636A
(en)
PHARMACEUTICAL COMPOSITION THAT INCLUDES DERIVATIVES OF GLUCOPIRANOSIL DIFENYLMETHANE, PHARMACEUTICAL FORM OF THE SAME, PROCEDURE FOR THEIR PREPARATION AND USES OF THE SAME FOR IMPROVED GLUCEMIC CONTROL IN A PATIENT.
Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide.
METHOD FOR THE TREATMENT OF A MAMIFERO THAT SUFFERS OF OSTEOARTRITIS THAT UNDERSTANDS TO ADMINISTER AN LXR AGONIST THAT MODULES THE EXPRESSION OF THE SENSITIVE LXR GEN; AND USE OF AN LXR AGONIST FOR THE TREATMENT OR PREVENTION OF OSTEOARTRITIS.
STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS
formulations for the preparation of oral immediate release tablets containing a low dosage of mifepristone for the treatment of endometriosis, tablets thereby obtained and their preparation process
Process for preparing a pharmaceutical dosage form comprising florfenicol or an analog thereof; and to recover florfenicol or an analog of a pharmaceutical composition.